Regions of papilloma virus E1 helicase involved in E1 oligomerization

Details for Australian Patent Application No. 2004200590 (hide)

Owner Boehringer Ingelheim (Canada) Ltd.

Inventors Archambault, Jacques

Agent Davies Collison Cave

Pub. Number AU-A-2004200590

Parent 47664

Filing date 13 February 2004

Wipo publication date 11 March 2004

International Classifications

C12N 015/37 Mutation or genetic engineering

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C07K 014/025 Peptides having more than 20 amino acids

A61K 038/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

4 March 2004 Complete Application Filed

11 March 2004 Application Open to Public Inspection

  Published as AU-A-2004200590

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200591-Permag Assist

2004200589-Reformer exercise apparatus